Prevention of Endotoxin-Induced Uveitis in Rats by Benfotiamine, a Lipophilic Analogue of Vitamin B1YADAV, Umesh C. S; SUBRAMANYAM, Sumitra; RAMANA, Kota V et al.Investigative ophthalmology & visual science. 2009, Vol 50, Num 5, pp 2276-2282, issn 0146-0404, 7 p.Article

Thiamine and benfotiamine prevent apoptosis induced by high glucose-conditioned extracellular matrix in human retinal pericytesBELTRAMO, Elena; NIZHERADZE, Konstantin; BERRONE, Elena et al.Diabetes/metabolism research and reviews (Print). 2009, Vol 25, Num 7, pp 647-656, issn 1520-7552, 10 p.Article

Synergistic Antiallodynic Interaction between Gabapentin or Carbamazepine and either Benfotiamine or Cyanocobalamin in Neuropathic RatsMIXCOATL-ZECUATL, Teresa; QUINONEZ-BASTIDAS, Geovanna N; CARAM-SALAS, Nadia L et al.Methods and findings in experimental and clinical pharmacology. 2008, Vol 30, Num 6, pp 431-441, issn 0379-0355, 11 p.Article

The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomized, placebo-controlled trialFRASER, David A; DIEP, Lien M; ANETTE HOVDEN, Inger et al.Diabetes care. 2012, Vol 35, Num 5, pp 1095-1097, issn 0149-5992, 3 p.Article

Benfotiamine Protects against Peritoneal and Kidney Damage in Peritoneal DialysisKIHM, Lars P; MÜLLER-KREBS, Sandra; ZEIER, Martin et al.Journal of the American Society of Nephrology. 2011, Vol 22, Num 5, pp 914-926, issn 1046-6673, 13 p.Article

LC Simultaneous Determination of Thioctic Acid, Benfotiamine and Cyanocobalamin in Thiotacid Compound CapsulesSALEM, Hesham.Chromatographia (Wiesbaden). 2010, Vol 72, Num 3-4, pp 327-330, issn 0009-5893, 4 p.Article

Ruthenium (III)-catalyzed oxidative cleavage of thiamine hydrochloride with N-bromosuccinimide in presence of hydrochloric acid medium: A kinetic and mechanistic approachMOHANA, K. N; RAMYA, K. R.Journal of molecular catalysis. A, Chemical. 2009, Vol 302, Num 1-2, pp 80-85, issn 1381-1169, 6 p.Article

A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetesSTIRBAN, A; POP, A; TSCHOEPE, D et al.Diabetic medicine. 2013, Vol 30, Num 10, pp 1204-1208, issn 0742-3071, 5 p.Article

Alcoholic neuropathy: possible mechanisms and future treatment possibilitiesCHOPRA, Kanwaljit; TIWARI, Vinod.British journal of clinical pharmacology. 2012, Vol 73, Num 3, pp 348-362, issn 0306-5251, 15 p.Article

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic NephropathyALKHALAF, Alaa; KLOOSTER, Astrid; BAKKER, Stephan J. L et al.Diabetes care. 2010, Vol 33, Num 7, pp 1598-1601, issn 0149-5992, 4 p.Article

Current Options and Perspectives in the Treatment of Diabetic Neuropathy : Diabetes, Obesity and Vascular Disease - An UpdateVÁRKONYI, Tamás; PUTZ, Zsuzsanna; KERESZTES, Katalin et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 27, pp 4981-5007, issn 1381-6128, 27 p.Article

Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitroSCHMID, Ursula; STOPPER, Helga; HEIDLAND, August et al.Diabetes/metabolism research and reviews (Print). 2008, Vol 24, Num 5, pp 371-377, issn 1520-7552, 7 p.Article

Benfotiamine in Diabetic Polyneuropathy (BENDIP) : Results of a Randomised, Double Blind, Placebo-controlled Clinical StudySTRACKE, H; GAUS, W; ACHENBACH, U et al.Experimental and clinical endocrinology & diabetes. 2008, Vol 116, Num 10, pp 600-605, issn 0947-7349, 6 p.Article